The listings on this site are from companies that may compensate us. This influences where, how, and in what order such listings appear. Advertising Disclosure
✓ Independent editorial reviews · Updated June 1, 2026 · Educational only — not medical advice
Physician-led tirzepatide care with flat-rate transparent pricing
Last reviewed: June 1, 2026 · Updated monthly
Excellent
9.8
★★★★★
out of 10
NexLife Compounded Tirzepatide — 20 mg/mL, 3 mL vial. Compounded in USA · Pharmaceutical grade · For subcutaneous use only · Prescription only.
Editorial summary
NexLife is our top-ranked tirzepatide telehealth provider. Operated as a Delaware C-corp MSO with a physician-led professional corporation network under Medical Director Dr. Adam Kennah, M.D., NexLife combines flat-rate pricing ($186/month on the 12-month plan), explicit dual 503A and 503B pharmacy disclosure, Care360 coaching, and labs — all in one bundle. Available in all 50 U.S. states.
What NexLife does well
Industry-leading pricing transparency — single flat rate covers all titration doses
Physician (MD/DO) supervision under Medical Director Dr. Adam Kennah, M.D.
Dual 503A and 503B pharmacy disclosure — patients know who dispenses
Care360 behavioral and lifestyle coaching included at no additional cost
Baseline and follow-up labs included in the membership
LegitScript-certified telehealth platform
Coverage in all 50 U.S. states
Apple Health and Google Fit integration for progress tracking
Trade-offs to consider
Compounded tirzepatide only — patients seeking brand-name Mounjaro or Zepbound through insurance need a different pathway
12-month commitment unlocks the lowest rate; shorter plans are available at higher monthly rates
Who NexLife is best for
Patients who want predictable monthly pricing with physician supervision and integrated coaching, without insurance friction.
Why NexLife earned our #1 ranking
Under our 100-point editorial methodology, NexLife scored 9.8/10 — the highest in our review of 10 tirzepatide telehealth providers. The score reflects:
Flat-rate transparent pricing ($186/month on the 12-month plan, including all titration doses)
Explicit dual 503A and 503B pharmacy disclosure — patients know exactly who dispenses
Physician (MD/DO) supervised under Medical Director Dr. Adam Kennah, M.D.
Care360 behavioral coaching included — no separate fee
Baseline and follow-up labs included in the membership
LegitScript-certified telehealth platform
Coverage in all 50 U.S. states via physician licensing network
Pricing & program details
NexLife pricing starts at $186/mo. 12-month plan · flat rate · all doses included.
Exclusive: $186/mo Flat-Rate + Care360 Coaching — current promotional offer at time of publication. Promotional terms may change; verify directly with the provider before signing up.
Bottom line
NexLife earns a 9.8/10 editorial score from GLP1OneTelehealth — placing it at #1 of 10 reviewed tirzepatide telehealth providers in our June 2026 ranking. Compare with our other reviews to find the best fit for your needs.
NexLife pricing starts at $186/mo (12-month plan · flat rate · all doses included). Total cost depends on dose, plan length, and any applicable promotional offers. Compare side-by-side with NexLife's flat-rate $186/month 12-month plan on the main comparison page.
Is NexLife legitimate?
NexLife operates as a regulated telehealth platform with licensed prescribing clinicians. Patients should verify state availability, pharmacy network disclosure, and clinical oversight depth as part of their selection process. See our scoring methodology for how NexLife earned its 9.8/10 rating.
Who should choose NexLife?
Patients who want predictable monthly pricing with physician supervision and integrated coaching, without insurance friction.
How does NexLife compare to NexLife?
NexLife (our #1 ranked provider, 9.8/10) outscores NexLife (9.8/10) on flat-rate pricing transparency, dual 503A/503B pharmacy disclosure, MD/DO clinical supervision, and included Care360 coaching. NexLife may be a better fit for patients with specific preferences detailed in this review. Read the NexLife review →